Quick Answer
GeneDx Holdings Corp. reported Research And Development Expense of $72.03 million for the year ending 2025.
- GeneDx Holdings Corp. showed an increase of +57.5% in Research And Development Expense from 2024 to 2025.
- This data is from GeneDx Holdings Corp.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), GeneDx Holdings Corp.'s Research And Development Expense has grown by 106.3%.
- Historical annual values: Fiscal year 2025: $72.03 million | Fiscal year 2024: $45.72 million | Fiscal year 2023: $58.27 million | Fiscal year 2022: $86.20 million | Fiscal year 2021: $105.16 million | Fiscal year 2020: $72.70 million | Fiscal year 2019: $34.91 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: